Contract manufacturing of ingredients for the Life Science Industry. We welcome your request.




In the race to bring your innovation to trials and commercialization the experience and know-how of your manufacturing partner means everything.


Our key personnel at Syntagon have the necessary experience from companies such as AstraZeneca, Pharmacia and Ferring and not the least from assisting over 100 innovative companies, world wide, over the last 15 years.


Syntagon also brings a technological edge needed when the manufacturing process requires HPLC purification on large scale or difficult manufacturing conditions such as cryogenic chemistry.


Our service portfolio, personal attention and focus on communication make us particularly suited to helping smaller innovative companies navigate through the regulatory requirements.

Syntagons complete website coming soon

Management Team

About Us

Technolgy Edge

Michael Lofthagen


PhD in organic chemistry (UC San Diego)

Co-founder of Syntagon

25 years of pharma experience

Ferring Pharmaceuticals (1985-1986)

AstraZeneca (1992-1999)

Syntagon (1999-)

Phone: +46 8 554 422 50



Paul Alhadeff

BSc General Manager

Co-founder of Syntagon

25 years of pharma experience

Kabi Pharmacia (1989-1992)

AstraZeneca (1992-1999)

Syntagon (1999-)

Phone: +46 8 554 422 50


Agnese Jurkevica

Site Manager Latvia


10 years of pharma experience


Phone: +371 674 90 884



Established in 1998, Syntagon enjoys a market leading position as a development and manufacturing partner in the Nordic region.


Syntagon holds extensive R&D as well as industrial know-how and offers a one-stop shop solution with a complete service range for development and manufacuring from the Candidate Drug selection up and through launch.



Syntagon has two MPA certifed facilities.


Syntagon AB is located in the dynamic Stockholm/Uppsala BioRegion and performs GMP

manufacturing and quality control.


Syntagon Baltic (Riga, Latvia), a very cost effective organization, carries out quality control as well as process R&D.



 ▪ Preparative HPLC systems (GMP).

 ▪ Cryogenic conditions up to 800 L reactor scale (GMP).

 ▪ Isolators allowing high potency compound handling (GMP).

 ▪ NMR determinations (GMP).

 ▪ Large scale thin film distillation for sensitive high boiling compounds (GMP)